"> 9-O-Alkanoyl-3
    1.
    发明授权
    9-O-Alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance and the production thereof 失效
    9-O-烷酰基-3 {41-烷酰氧基甲基-SF-837物质及其制备

    公开(公告)号:US3959256A

    公开(公告)日:1976-05-25

    申请号:US505310

    申请日:1974-09-12

    IPC分类号: C07H17/08

    CPC分类号: C07H17/08

    摘要: A 9-O-alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance is now synthetized, which is a new compound useful in that this new 9-O-alkanoyl-3"-O-alkanoyloxymethyl derivative of the SF-837 substance exhibits an antibacterial activity comparable to that of the parent SF-837 substance but is advantageously free from the unpleasant bitter taste inherent to the SF-837 substance and is hence adapted for oral administration. A process of producing the 9-O-alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance is also provided, which comprises hydrolysing partially and selectively a 9,2'-di-O-alkanoyl-3"-O-alkanoyloxymethyl-SF-837 substance in an aqueous alkanol or aqueous acetone. The 9,2'-di-O-alkanoyl-3"-O-alkanopyloxymethyl-SF-837 substance may be prepared by reacting a 9,2'-di-alkanoyl- or O-mono-O-alkanoyl-3"-O-thiomethoxymethyl-SF-837 substance with an alkanoic anhydride which is exemplified by acetic anhydride or propionic anhydride in the specification.

    摘要翻译: 现在合成了9-O-烷酰基-3“-O-烷酰氧基甲基-SF-837物质,这是一种新的化合物,有用的是这种新型的9-O-烷酰基-3'-O-烷酰氧基甲基衍生物 -837物质表现出与母体SF-837物质相当的抗菌活性,但有利地没有SF-837物质固有的不愉快的苦味,因此适于口服给药。 还提供了制备9-O-烷酰基-3“-O-烷酰氧基甲基-SF-837物质的方法,其包括部分和选择性地水解9,2'-二-O-烷酰基-3'-O - 烷酰氧基甲基-SF-837物质在链烷醇水溶液或丙酮水溶液中。 9,2'-二-O-烷酰基-3“-O-烷酰氧基甲基-SF-837物质可以通过使9,2'-二烷酰基或O-单-O-烷酰基-3' 具有链烷酸酐的“-O-硫代甲氧基甲基-SF-837”物质,其例示在说明书中的乙酸酐或丙酸酐。

    "> 9,3
    2.
    发明授权
    9,3",4"-Triacyl ester of the antibiotic SF-837 M.sub.1 substance and the production thereof 失效
    9,3 {41,4 {41-抗生素SF-837M {HD 1 {B物质及其制备的三

    公开(公告)号:US4017607A

    公开(公告)日:1977-04-12

    申请号:US597188

    申请日:1975-07-18

    CPC分类号: C07H17/08

    摘要: As new compounds are provided 9,3",4"-trialkanoyl SF-837 M.sub.1 substances which have therapeutically useful antibacterial activity and do not show any objectionable long-lasting bitter taste upon its oral administration. These 9,3",4"-trialkanoyl SF-837 M.sub.1 substances may be prepared from SF-837 substance, 9,2',3"-tri-acetyl SF-837 M.sub.1 substance, 9,2'-di-acetyl SF-837 substance, 9-propionyl SF-837 substance or 9,2'-dipropionyl SF-837 substance by acylating the latter with an alkanoic acid anhydride at 50.degree.-120.degree. C to produce the corresponding 9,2',3",4"-tetra-alkanoyl SF-837 M.sub.1 substance and occasionally the 9,18,2',3",4"-penta-alkanoyl SF-837 M.sub.1 substance, with involving the shift of the 4"-alkanoyl group to the 3"-hydroxyl group. Partial and selective hydrolysis of the 9,2',3",4"-tetra-alkanoyl SF-837 M.sub.1 substance and/or the 9,18,2',3",4"-penta-alkanoyl SF-837 M.sub.1 substance so produced gives the desired 9,3",4"-tri-alkanoyl SF-837 M.sub.1 substance.

    摘要翻译: 当新化合物被提供具有治疗上有用的抗菌活性的9,3“,4” - 三烷酰基SF-837M1物质,并且在其口服给药时不显示任何令人不快的持久苦味。 这些9,3“,4” - 三烷酰基SF-837 M1物质可以由SF-837物质,9,2',3“ - 三乙酰基SF-837M1物质,9,2'-二 - 乙酰基SF-837物质,9-丙酰基SF-837物质或9,2'-二丙酰基SF-837物质,通过用烷基酸酐在50°-120℃下酰化后者,产生相应的9,2' 3“,4” - 四烷酰基SF-837 M1物质,偶尔有9,18,2',3“,4” - 五烷酰基SF-837 M1物质,涉及4 “ - 烷酰基与3” - 羟基。 9,2',3“,4” - 四烷酰基SF-837 M1物质和/或9,18,2',3“,”4“ - 五烷酰基SF- 837如此生产的M1物质得到所需的9,3“,”4“ - 三烷酰基SF-837 M1物质。

    Process for the production of a cephamycin derivative
    3.
    发明授权
    Process for the production of a cephamycin derivative 失效
    生产头孢霉素衍生物的方法

    公开(公告)号:US4302580A

    公开(公告)日:1981-11-24

    申请号:US185594

    申请日:1980-09-09

    CPC分类号: C12P35/08

    摘要: A chemotherapeutic, antibacterial agent, 7.beta.-[(2D-2-amino-2-carboxy)ethylthioacetamido]-7.alpha.-methoxy-3-[(1-methyl-1H-tetrazole-5-yl)thiomethyl]-3-cephem-4-carboxylic acid is produced economically and efficiently starting from cephamycin A and/or B by a "new route" process comprising the consecutive steps of reaction of cephamycin with 5-mercapto-1-methyl-1H-tetrazole; protection of the terminal amino group thereof by acylation; protection of the two carboxyl groups thereof by esterification; replacement of the acyl group initially having attached to the 7-amino group by a halogenoacetyl group; deprotection of the blocked 4-carboxyl group; and condensation of D-cysteine with the halogenoacetyl group attaching to the 7-amino group.

    摘要翻译: 7β-[(2D-2-氨基-2-羧基)乙硫基乙酰氨基]-7α-甲氧基-3 - [(1-甲基-1H-四唑-5-基)硫代甲基] -3- 头孢霉素-4-羧酸从头孢霉素A和/或B开始通过包含头孢霉素与5-巯基-1-甲基-1H-四唑的连续步骤的“新途径”方法经济有效地产生; 通过酰化保护其末端氨基; 通过酯化保护其两个羧基; 用卤代乙酰基取代最初连接在7-氨基上的酰基; 封闭的4-羧基脱保护; 和D-半胱氨酸与连接于7-氨基的卤代乙酰基缩合。

    5-Substituted picolinic acid derivatives and an anti-hypertensive
composition containing the same
    4.
    发明授权
    5-Substituted picolinic acid derivatives and an anti-hypertensive composition containing the same 失效
    5-取代的吡啶甲酸衍生物和含有它们的抗高血压组合物

    公开(公告)号:US4229448A

    公开(公告)日:1980-10-21

    申请号:US23504

    申请日:1979-03-23

    摘要: 5-Substituted picolinic acid derivatives represented by the formula (I): ##STR1## wherein R.sub.1 represents a straight or branched chain halogen-substituted alkyl group having 2 to 6 carbon atoms or a substituted phenyl group having the formula ##STR2## wherein R.sub.3 and R.sub.4, which may be the same or different, each represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a nitro group, an amino group, an N-alkyl-substituted amino group, an acylamino group, an acetyl group, an acyloxy group, a hydroxy group or a halogen-substituted alkyl group or R.sub.3 and R.sub.4, when taken together, represent a polymethylene chain; and R.sub.2 represents an --OM group wherein M represents a hydrogen, sodium, potassium, calcium, aluminium or magnesium atom, a straight or branched chain or cyclic alkoxy group having 1 to 6 carbon atoms, an aminoalkoxy group, a phenoxy group, a substituted phenoxy group, a 5-indanyloxy group, an acyloxyalkyloxy group having the formula ##STR3## wherein R.sub.5 represents a hydrogen atom or a methyl group and R.sub.6 represents a lower alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group, or an amino group represented by the formula ##STR4## wherein R.sub.7 and R.sub.8, which may be the same or different, each represents a hydrogen atom, a lower alkyl group, or a phenyl group which are useful as anti-hypertensive agents, a process for preparing the above 5-substituted picolinic acid derivatives, and anti-hypertensive compositions containing the same.

    摘要翻译: 由式(I)表示的5-取代的吡啶甲酸衍生物:其中R 1表示具有2至6个碳原子的直链或支链卤素取代的烷基或具有下式的取代苯基: 其中可以相同或不同的R 3和R 4各自表示氢原子,卤素原子,低级烷基,低级烷氧基,硝基,氨基,N-烷基取代的氨基, 酰氨基,乙酰基,酰氧基,羟基或卤素取代的烷基,或者R 3和R 4一起表示聚亚甲基链; R 2表示-OM基,其中M表示氢,钠,钾,钙,铝或镁原子,具有1至6个碳原子的直链或支链或环状烷氧基,氨基烷氧基,苯氧基,取代的 苯氧基,5-茚满氧基,具有式“IMAGE”的酰氧基烷氧基,其中R5表示氢原子或甲基,R6表示碳原子数1〜6的低级烷基,苯基或取代苯基 或由式“IMAGE”表示的氨基,其中R7和R8可以相同或不同,表示可用作抗高血压剂的氢原子,低级烷基或苯基, 制备上述5-取代的吡啶甲酸衍生物的方法和含有它们的抗高血压组合物。

    5-Alkoxy-picolinic esters and anti-hypertensive composition containing
5-alkoxy-picolinic esters
    8.
    发明授权
    5-Alkoxy-picolinic esters and anti-hypertensive composition containing 5-alkoxy-picolinic esters 失效
    5-烷氧基 - 吡啶甲酸酯和含有5-烷氧基 - 吡啶甲酸酯的抗高血压组合物

    公开(公告)号:US4198416A

    公开(公告)日:1980-04-15

    申请号:US944683

    申请日:1978-09-22

    CPC分类号: C07D213/79 C07D213/65

    摘要: 5-Alkoxy-picolinic esters represented by the formula (I): ##STR1## wherein R represents an alkyl group having 1 to 6 carbon atoms and R.sub.1 represents an unsubstituted phenyl group; a phenyl group substituted with one or more of an alkyl group having 1 to 4 carbon atoms or an acetyl group; a phthalidyl group; an alkoxyalkyl group wherein the alkyl moiety and the alkoxy moiety each has 1 to 4 carbon atoms; an alkoxyalkoxyalkyl group wherein the alkyl moiety and the alkoxy moiety each has 1 to 4 carbon atoms; an indanyl group; or an acyloxyalkyl group having the formula ##STR2## wherein R.sub.2 represents a hydrogen atom or a methyl group and R.sub.3 represents an alkyl group having 1 to 5 carbon atoms (such as a methyl, n-propyl, isobutyl, t-butyl, etc., group), an alkoxy group having 1 to 4 carbon atoms, a phenyl group, a phenyl group substituted with one or more of an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms or a halogen atom (such as chlorine, bromine, iodine, etc., atom) or an aralkyl group wherein the alkyl moiety has 1 to 3 carbon atoms, which are useful as anti-hypertensive agents, a process for preparing 5-alkoxy-picolinic esters, and anti-hypertensive compositions containing the 5-alkoxy-picolinic esters.

    摘要翻译: 由式(I)表示的5-烷氧基 - 吡啶甲酸酯:其中R表示具有1至6个碳原子的烷基,R 1表示未取代的苯基; 被一个或多个具有1至4个碳原子的烷基或乙酰基取代的苯基; 苯酞基; 其中烷基部分和烷氧基部分各自具有1至4个碳原子的烷氧基烷基; 其中烷基部分和烷氧基部分各自具有1至4个碳原子的烷氧基烷氧基烷基; 茚满基; 或具有式“IMAGE”的酰氧基烷基,其中R 2表示氢原子或甲基,R 3表示具有1至5个碳原子的烷基(例如甲基,正丙基,异丁基,叔丁基等) ,基团),具有1至4个碳原子的烷氧基,苯基,被一个或多个具有1至4个碳原子的烷基取代的苯基,具有1至4个碳原子的烷氧基或卤素原子 (例如氯,溴,碘等原子)或其中烷基部分具有1〜3个碳原子的芳烷基,其可用作抗高血压剂,制备5-烷氧基 - 吡啶甲酸酯的方法和 含有5-烷氧基 - 吡啶甲酸酯的抗高血压组合物。